Novo Nordisk Research and Development Expenses 2010-2024 | NVO
Novo Nordisk research and development expenses for the twelve months ending June 30, 2024 were $6.286B, a 61.25% increase year-over-year.
- Novo Nordisk annual research and development expenses for 2023 were $4.711B, a 38.35% increase from 2022.
- Novo Nordisk annual research and development expenses for 2022 were $3.405B, a 20.43% increase from 2021.
- Novo Nordisk annual research and development expenses for 2021 were $2.828B, a 19.37% increase from 2020.